{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:56Z","timestamp":1790087876591,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","award":["1819-HQ-000036"],"award-info":[{"award-number":["1819-HQ-000036"]}],"id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jsat.2021.108404","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T18:42:57Z","timestamp":1618771377000},"page":"108404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The cascade of care for opioid use disorder among youth in British Columbia, 2018"],"prefix":"10.1016","volume":"130","author":[{"given":"Emanuel","family":"Krebs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong E.","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsat.2021.108404_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5183","article-title":"Receipt of addiction treatment after opioid overdose among medicaid-enrolled adolescents and young adults","volume":"174","author":"Alinsky","year":"2020","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.jsat.2021.108404_bb0010","article-title":"Medication-assisted treatment of adolescents with opioid use disorders - Committee on substance use and prevention","volume":"138","author":"American Academy of Pediatrics","year":"2016","journal-title":"Pediatrics"},{"issue":"10182","key":"10.1016\/j.jsat.2021.108404_bb0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: Present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2021.108404_bb0020","series-title":"A guideline for the clinical management of opioid use disorder","author":"British Columbia Centre on Substance Use","year":"2017"},{"key":"10.1016\/j.jsat.2021.108404_bb0025","series-title":"A guideline for the clinical management of opioid use disorder\u2014youth supplement","author":"British Columbia Centre on Substance Use","year":"2018"},{"key":"10.1016\/j.jsat.2021.108404_bb0030","series-title":"A pathway to hope: A roadmap for making mental health and addictions care better for people in British Columbia","author":"British Columbia Ministry of Mental Health and Addictions","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2021.108404_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00952990.2017.1399403","article-title":"Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions","volume":"44","author":"Chang","year":"2018","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108404_bb0040","series-title":"The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update","author":"Cunningham","year":"2020"},{"issue":"6","key":"10.1016\/j.jsat.2021.108404_bb0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder","volume":"60","author":"Feder","year":"2017","journal-title":"Journal of Adolescent Health"},{"key":"10.1016\/j.jsat.2021.108404_bb0050","author":"Foundry"},{"issue":"8","key":"10.1016\/j.jsat.2021.108404_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6558","article-title":"US National Trends in pediatric deaths from prescription and illicit opioids, 1999-2016","volume":"1","author":"Gaither","year":"2018","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.jsat.2021.108404_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection","volume":"52","author":"Gardner","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1016\/j.jsat.2021.108404_bb0065","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.jsat.2021.108404_bb0070","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1016\/j.amepre.2020.03.022","article-title":"Opioid use disorder treatment facilities with programs for special populations","volume":"59","author":"Hadland","year":"2020","journal-title":"American Journal of Preventive Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2021.108404_bb0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.jsat.2021.108404_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2017.02.006","article-title":"The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample","volume":"175","author":"Krawczyk","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108404_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M17-0611","article-title":"Cost-effectiveness of publicly funded treatment of opioid use disorder in California","volume":"168","author":"Krebs","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2021.108404_bb0090","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2752","article-title":"Youth and the opioid epidemic","volume":"143","author":"Levy","year":"2019","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jsat.2021.108404_bb0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s40429-019-00272-0","article-title":"Treatment of opioid use disorder in pediatric medical settings","volume":"6","author":"Levy","year":"2019","journal-title":"Current Addiction Reports"},{"issue":"3","key":"10.1016\/j.jsat.2021.108404_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08897077.2018.1550467","article-title":"Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients","volume":"40","author":"Lind","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108404_bb0105","article-title":"Maintenance treatments for opiate-dependent adolescents","volume":"6","author":"Minozzi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2021.108404_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1473-3099(13)70254-8","article-title":"The cascade of HIV care in British Columbia, Canada, 1996\u20132011: A population-based retrospective cohort study","volume":"14","author":"Nosyk","year":"2014","journal-title":"The Lancet Infectious Diseases"},{"issue":"5","key":"10.1016\/j.jsat.2021.108404_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","author":"O\u2019Connor","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2021.108404_bb0120","author":"Office of the Surgeon General"},{"issue":"3","key":"10.1016\/j.jsat.2021.108404_bb0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jama.2019.18913","article-title":"Trends in buprenorphine treatment in the United States, 2009-2018","volume":"323","author":"Olfson","year":"2020","journal-title":"JAMA\u202f: The Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2021.108404_bb0130","doi-asserted-by":"crossref","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Mortality among people with opioid use disorder during an opioid overdose public health emergency in British Columbia, Canada","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jsat.2021.108404_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036102","article-title":"Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: A population-based observational study protocol in British Columbia, Canada","volume":"10","author":"Piske","year":"2020","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.jsat.2021.108404_bb0140","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.14947","article-title":"The cascade of care for opioid use disorder: A retrospective study in British Columbia, Canada","volume":"115","author":"Piske","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108404_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2019.01.020","article-title":"Comparing Canadian and United States opioid agonist therapy policies","volume":"74","author":"Priest","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"Supplement 2","key":"10.1016\/j.jsat.2021.108404_bb0150","article-title":"Management of opioid misuse and opioid use disorders among youth","volume":"145","author":"Robinson","year":"2020","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jsat.2021.108404_bb0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1377\/hlthaff.2019.01041","article-title":"Treatment of opioid use disorder among commercially insured US adults, 2008\u201317: Study examines how Medicare rural add-on payments affected the number of home health agencies serving rural counties","volume":"39","author":"Shen","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2021.108404_bb0160","series-title":"Concurrent substance use and mental health disorders","author":"Skinner","year":"2004"},{"issue":"1","key":"10.1016\/j.jsat.2021.108404_bb0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-018-1137-4","article-title":"Opioid substitution treatment and heroin dependent adolescents: Reductions in heroin use and treatment retention over twelve months","volume":"18","author":"Smyth","year":"2018","journal-title":"BMC Pediatrics"},{"key":"10.1016\/j.jsat.2021.108404_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","article-title":"Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006\u20132016","volume":"189","author":"Soc\u00edas","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108404_bb0175","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jsat.2021.108404_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/epirev\/mxaa001","article-title":"Adherence to and retention in medications for opioid use disorder among adolescents and young adults","volume":"42","author":"Viera","year":"2020","journal-title":"Epidemiologic Reviews"},{"issue":"7","key":"10.1016\/j.jsat.2021.108404_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis","volume":"9","author":"Yehia","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:45Z","timestamp":1760039625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"alternative-id":["S0740547221001306"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108404","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cascade of care for opioid use disorder among youth in British Columbia, 2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108404"}}